Regulation of GSK-3 Activity as A Shared Mechanism in Psychiatric Disorders
Glycogen synthase kinase-3 (GSK-3), a member of the serine/threonine kinase family was first identified as an inhibitor of the metabolic enzyme glycogen synthase and is now accepted as a widely influential enzyme responsible for many intracellular regulatory mechanisms with over 50 known substrates...
Uloženo v:
| Hlavní autoři: | , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Mesut Çetin
2021-02-01
|
| Edice: | Psychiatry and Clinical Psychopharmacology |
| Témata: | |
| On-line přístup: | https://psychiatry-psychopharmacology.com/index.php/pub/article/view/2863 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|